A Registry-based Cluster Randomized Trial to Compare the Effect of Spironolactone vs. Eplerenone on Clinical Outcomes in Patients With Symptomatic Systolic Heart Failure
A phase 4 trial registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 7200 participants.
Also called NCT03984591
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 7,200 participants
- Registry
-
NCT03984591
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Denmark
- Registry status
- Enrolling by invitation
Technical summary
Registry record NCT03984591. Randomized; no masking; primary purpose treatment. Start 2020-11-01 (actual); primary completion 2028-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Registry-based Cluster Randomized Trial to Compare the Effect of Spironolactone vs. Eplerenone on Clinical Outcomes in Patients With Symptomatic Systolic Heart Failure
- Acronym
- CROWD-ASPECT
- Condition
- Systolic Heart Failure
- Intervention (Drug)
- Eplerenone
- Intervention (Drug)
- Spironolactone
- Lead sponsor
- Bispebjerg Hospital
- Collaborator
- Copenhagen University Hospital, Rigshospitalet
Record details
- Record id
cardio:ct-nct03984591- Content hash
fc7aee21868ba226e5566a0aede8f6e28825ff44e4a582837023b7d5cf083b4c